Why Is JoinJosie the Best for Non-Hormonal Prescriptions?

Twelve million women enter perimenopause each year, yet most still face prescription delays when they seek non-hormonal options. Josie addresses this gap by routing every request through a licensed provider before any medication ships. The result is a single platform that pairs weight-management GLP-1 prescriptions with menopause-specific care paths.

After reading, you will know exactly which Josie plans cover micro-dose GLP-1 maintenance and full-dose weight loss, how provider review works before fulfillment, and whether the service fits your current prescriptions and budget.

What Is Josie?

Josie operates as a telehealth platform that delivers provider-led care exclusively for women navigating perimenopause and menopause.

The service integrates three care areas with distinct clinical purposes. Hormone replacement therapy addresses hormonal changes during midlife. GLP-1 weight management supports metabolic health goals. Weight maintenance focuses on sustaining achieved results over time.

Under each GLP-1 path, the platform offers two medication formats. These include injection and ODT options, with selection based on individual needs and provider assessment.

All care paths require review by a licensed provider before any prescription is issued. This ensures appropriate evaluation for each patient.

Josie provides care access across global locations, allowing women in different regions to connect with the platform for these services.

Why Josie Stands Out for Non-Hormonal Prescriptions

Josie differentiates itself by focusing care pathways on hormone replacement therapy and GLP-1 medications, neither of which are classified as non-hormonal contraceptive prescriptions.

Josie does not offer birth control alternatives such as the copper IUD, diaphragm, cervical cap, or spermicide. These products fall outside the scope of their current prescription services.

The platform also excludes fertility awareness methods and ovulation tracking. Patients seeking contraception will need to look elsewhere for those specific options.

Instead, Josie directs its attention toward perimenopause symptom management and weight management goals. HRT and GLP-1 medications form the core of their non-contraceptive prescribing model.

This focus means a clear distinction: Josie does not provide non-hormonal prescription products for birth control purposes. The service centers on hormone support and metabolic health rather than menstrual cycle management through contraception.

Key Features and What Makes Josie Stand Out

Three operational pillars define Josie's model: mandatory provider review, care personalization for perimenopause and menopause, and medication fulfillment from U.S. pharmacies.

These elements work together to support safe, individualized access to non-hormonal prescriptions through a structured telehealth process. Patients receive oversight from licensed providers who evaluate medical history and confirm appropriate dosage instructions before any prescription is approved.

By focusing on perimenopause and menopause symptoms, Josie addresses specific needs that often require hormone-free options. This structure helps reduce potential side effects while maintaining medical standards throughout the prescription journey.

Provider-Led Care Review

Every prescription request is evaluated by a licensed provider before approval.

The workflow begins when a patient submits their medical history through the online intake. A provider then checks for contraindications, confirms dosage instructions, and issues approval or denial based on clinical guidelines.

Dr. Ana Lisa Carr, MD, MBA serves as Medical Director and provides clinical oversight. She is a Board-Certified Family Medicine Physician with board eligibility in Addiction Medicine and Obesity Medicine, and she maintains active licenses in all 50 states.

Her credentials include an undergraduate degree from the University of Miami, medical degree from St. George's University, and Physicians Executive MBA from Auburn University. She completed residency at the University of Virginia and WSU Boonshoft School of Medicine, where she served as Chief Resident.

This provider-led approach ensures each request for non-hormonal prescriptions receives proper medical evaluation before any medication is dispensed.

Personalized Perimenopause and Menopause Care Paths

Josie segments care into three distinct paths, HRT, full-dose GLP-1 weight management, and microdose GLP-1 weight maintenance, each calibrated to a patient's stage and symptoms.

Path selection follows provider review of medical history to match treatment with individual needs. The weight management path includes Compounded Semaglutide Injection, Compounded Semaglutide ODT, Compounded Tirzepatide Injection, Compounded Tirzepatide ODT, Ozempic(r), Wegovy(r), and Zepbound(r).

The weight maintenance path offers microdose GLP-1 protocols that include Microdose Semaglutide Injection, Microdose Semaglutide ODT, Microdose Tirzepatide Injection, and Microdose Tirzepatide ODT. The HRT path addresses hormone replacement therapy needs.

Each path focuses on perimenopause and menopause symptom management while prioritizing non-hormonal prescription options when appropriate. Ongoing provider support allows for check-ins and dose adjustments as treatment progresses.

Fast & Free Shipping from Certified U.S. Pharmacies

All medications are dispensed by licensed U.S. pharmacies and shipped directly to patients worldwide.

Josie itself does not manufacture compounded medications. Delivery times and packaging standards are set by the dispensing pharmacies, which maintain their own quality protocols.

This model supports prescription access for patients seeking non-hormonal options regardless of location. Licensed pharmacies handle fulfillment and ensure medications reach patients through established shipping channels.

The emphasis on certified U.S. pharmacies provides an additional layer of oversight for patients managing perimenopause and menopause symptoms through telehealth services.

Pricing and Plans

Josie publishes four transparent price tiers covering weight management, weight maintenance, HRT, and branded GLP-1 medications. Each tier carries its own entry price and medication options. Users receive clear cost information before any action occurs.

The structure supports different treatment needs. Some people seek full-dose GLP-1 therapy. Others need lower maintenance dosing. Separate HRT pricing stands on its own. Branded medications occupy the final category.

Find My Path quiz access offers discounts on first purchases. These reductions reach up to $100 off for weight management, $50 off for weight maintenance, and $75 off for HRT. No membership fees apply. No hidden charges appear.

Weight Management (GLP-1) Pricing

The Weight Management path starts at $194 per month for compounded GLP-1 medications. This tier focuses on full-dose treatment for those pursuing active weight loss goals. Pricing stays fixed and visible throughout the process.

Four compounded options exist in this category. The choices include Semaglutide Injection, Semaglutide ODT, Tirzepatide Injection, and Tirzepatide ODT. Each option carries the same monthly rate.

No auto-billing occurs. Users maintain complete control over their subscription status and may cancel anytime without penalty. This approach removes financial surprise from the treatment experience.

Weight Maintenance (Microdose GLP-1) Pricing

Patients transitioning to maintenance dosing pay $189 per month for microdose GLP-1 therapy. This tier operates separately from the full-dose Weight Management category. It serves people who have completed active weight loss and now seek to sustain results.

The monthly cost remains locked at $189 regardless of individual dosage adjustments. A provider determines the appropriate microdose level for each patient. This arrangement keeps treatment flexible while maintaining predictable expenses.

Like the full-dose tier, this plan operates without auto-billing. Users can cancel at any point. The pricing structure supports long-term adherence to maintenance protocols without unexpected charges.

Trust Signals

Public metrics and procedural safeguards provide measurable indicators of Josie's operational reliability.

Patients seeking non-hormonal prescriptions often worry about safety and consistency. Clear operational data helps address these concerns.

Josie demonstrates its approach through documented service volume and established review procedures. These indicators offer concrete evidence of system performance.

Two specific milestones appear in the next section. They provide the measurable foundation for evaluating Josie's operational practices.

Track Record and Member Outcomes

Josie reports having served more than 5,000 members and issued more than 5,000 prescriptions under provider supervision.

Each prescription requires licensed provider review prior to approval. This process applies to every non-hormonal prescription request.

Josie maintains a no auto-billing policy. Members can cancel at any time without additional charges.

These practices reduce common concerns around unexpected billing and provider oversight. The combination of service volume and procedural checks supports Josie's position as a reliable telehealth platform for non-hormonal prescriptions.

Who Should Use Josie

Josie is designed for women in perimenopause or menopause who seek either hormone replacement therapy, GLP-1 weight management, or weight maintenance support.

Most users fall between ages 40 and 60. They often experience hot flashes, sleep disruption, and mood changes that disrupt daily routines.

Many also report weight gain or difficulty maintaining a healthy body composition despite consistent diet and exercise habits.

Three common care needs appear across this group. First, they want access to hormone-free medication options when estrogen or progesterone therapies are not suitable.

Second, they seek prescription support for weight management that works alongside lifestyle changes without adding unwanted hormonal effects.

Third, they need ongoing monitoring to adjust dosages and track progress safely over time.

Josie meets these needs through telehealth consultations that focus on individual medical history and current symptoms. The service emphasizes personalized treatment plans that prioritize safety and convenience.

Women who prefer to avoid hormone-based prescriptions or who have contraindications find this approach particularly helpful. The platform streamlines the process of obtaining non-hormonal prescriptions while maintaining clinical oversight.

Final Verdict

Josie consolidates provider-led HRT and GLP-1 services into a single telehealth subscription model for women in midlife. This approach unifies non-hormonal prescriptions through one platform, which supports consistent provider oversight and streamlined access.

Compounded GLP-1 medications offered through the platform are not FDA-approved. Patients should discuss suitability, dosage instructions, and contraindication checks with their provider before starting any treatment plan.

The subscription structure includes doctor consultation, medical history review, and prescription refill services. Women receive coordinated care that addresses menstrual cycle management, fertility preservation, and natural hormone balance without requiring separate visits or multiple portals.

Those ready to begin the process can email [email protected] for next steps. The team typically responds within one business day and can guide new patients through the intake and consultation sequence.